Durect Corp (NAS:DRRX)
$ 0.95 -0.0181 (-1.87%) Market Cap: 29.49 Mil Enterprise Value: 32.85 Mil PE Ratio: 0 PB Ratio: 24.36 GF Score: 56/100

Q4 2021 DURECT Corp Earnings Call Transcript

Mar 07, 2022 / 09:30PM GMT
Release Date Price: $5.8 (-5.71%)
Operator

Greetings and welcome to the DURECT Corporation Fourth Quarter 2021 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. (Operator Instructions) Please note that this conference is being recorded.

I will now turn the conference over to our host, Mike Arenberg, Chief Financial Officer. Thank you, sir. You may begin.

Michael Arenberg

Good afternoon and welcome to our fourth quarter 2021 earnings conference call. This is Mike Arenberg, Chief Financial Officer of DURECT Corporation.

Before beginning, I would like to remind you our safe harbor statement. During the course of this call, we may make forward-looking statements regarding DURECT's products and development, expected product benefits, our development plans, future clinical trials or projected financial results.

These forward-looking statements involve risks and uncertainties that can cause actual results to differ materially from those in such forward-looking statements. Further information

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot